• 1
    Porter RL, Calvi LM. Communications between bone cells and hematopoietic stem cells. Arch Biochem Biophys 2008; 473: 193200.
  • 2
    Calvi LM, Adams GB, Weibrecht KW et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425: 841846.
  • 3
    Adams GB, Martin RP, Alley IR et al. Therapeutic targeting of a stem cell niche. Nat Biotechnol 2007; 25: 238243.
  • 4
    Mendez-Ferrer S, Michurina TV, Ferraro F et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010; 466: 829834.
  • 5
    Bromberg O, Frisch BJ, Weber JM et al. Osteoblastic N-Cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells. Blood 2012; 120: 303313.
  • 6
    Tetradis S, Pilbeam CC, Liu Y et al. Parathyroid hormone increases prostaglandin G/H synthase-2 transcription by a cyclic adenosine 3′,5′-monophosphate-mediated pathway in murine osteoblastic MC3T3-E1 cells. Endocrinology 1997; 138: 35943600.
  • 7
    Tintut Y, Parhami F, Tsingotjidou A et al. 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem 2002; 277: 1422114226.
  • 8
    North TE, Goessling W, Walkley CR et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 2007; 447: 10071011.
  • 9
    Goessling W, North TE, Loewer S et al. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 2009; 136: 11361147.
  • 10
    Hoggatt J, Singh P, Sampath J et al. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood 2009; 113: 54445455.
  • 11
    Frisch BJ, Porter RL, Gigliotti BJ et al. In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells. Blood 2009; 114: 40544063.
  • 12
    Goessling W, Allen RS, Guan X et al. Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. Cell Stem Cell 2011; 8: 445458.
  • 13
    Ippoliti AF, Isenberg JI, Maxwell V et al. The effect of 16,16-dimethyl prostaglandin E2 on meal-stimulated gastric acid secretion and serum gastrin in duodenal ulcer patients. Gastroenterology 1976; 70: 488491.
  • 14
    Ippoliti AF, Isenberg JI, Hagie L. Effect of oral and intravenous 16,16-dimethyl prostaglandin E2 in duodenal ulcer and Zollinger-Ellison syndrome patients. Gastroenterology 1981; 80: 5559.
  • 15
    Frisch BJ, Ashton JM, Xing L et al. Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. Blood 2012; 119: 540550.
  • 16
    Vassiliou E, Sharma V, Jing H et al. Prostaglandin E2 promotes the survival of bone marrow-derived dendritic cells. J Immunol 2004; 173: 69556964.
  • 17
    Neilan TG, Doherty GA, Chen G et al. Disruption of COX-2 modulates gene expression and the cardiac injury response to doxorubicin. Am J Physiol Heart Circ Physiol 2006; 291: H532536.
  • 18
    Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995; 83: 493501.
  • 19
    Sheng H, Shao J, Morrow JD et al. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998; 58: 362366.
  • 20
    Pelus LM, Hoggatt J, Singh P. Pulse exposure of haematopoietic grafts to prostaglandin E2 in vitro facilitates engraftment and recovery. Cell Prolif 2011; 44(suppl 1): 2229.
  • 21
    Belkacemi Y, Bouchet S, Frick J et al. Monitoring of residual hematopoiesis after total body irradiation in humans as a model for accidental x-ray exposure: Dose-effect and failure of ex vivo expansion of residual stem cells in view of autografting. Int J Radiat Oncol Biol Phys 2003; 57: 500507.
  • 22
    Grande T, Varas F, Bueren JA. Residual damage of lymphohematopoietic repopulating cells after irradiation of mice at different stages of development. Exp Hematol 2000; 28: 8795.
  • 23
    Stewart FM, Zhong S, Lambert JF et al. Host marrow stem cell potential and engraftability at varying times after low-dose whole-body irradiation. Blood 2001; 98: 12461251.
  • 24
    Notta F, Doulatov S, Laurenti E et al. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 2011; 333: 218221.
  • 25
    Gentile P, Byer D, Pelus LM. In vivo modulation of murine myelopoiesis following intravenous administration of prostaglandin E2. Blood 1983; 62: 11001107.
  • 26
    Bradley TR, Hodgson GS. Detection of primitive macrophage progenitor cells in mouse bone marrow. Blood 1979; 54: 14461450.
  • 27
    Ebbe S, Stohlman F, Jr., Donovan J et al. Megakaryocyte maturation rate in thrombocytopenic rats. Blood 1968; 32: 787795.
  • 28
    Tanum G. The megakaryocyte DNA content and platelet formation after the sublethal whole body irradiation of rats. Blood 1984; 63: 917920.
  • 29
    Huang Q, Li F, Liu X et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med 2011; 17: 860866.
  • 30
    O'Banion MK. Cyclooxygenase-2: Molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol 1999; 13: 4582.
  • 31
    Fordyce C, Fessenden T, Pickering C et al. DNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions. Cancer Prev Res (Phila) 2010; 3: 190201.
  • 32
    Buckman SY, Gresham A, Hale P et al. COX-2 expression is induced by UVB exposure in human skin: Implications for the development of skin cancer. Carcinogenesis 1998; 19: 723729.
  • 33
    Pilbeam CC, Kawaguchi H, Hakeda Y et al. Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells. J Biol Chem 1993; 268: 2564325649.
  • 34
    Minghetti L, Nicolini A, Polazzi E et al. Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors. Glia 1997; 19: 152160.
  • 35
    Fournier T, Fadok V, Henson PM. Tumor necrosis factor-alpha inversely regulates prostaglandin D2 and prostaglandin E2 production in murine macrophages. Synergistic action of cyclic AMP on cyclooxygenase-2 expression and prostaglandin E2 synthesis. J Biol Chem 1997; 272: 3106531072.
  • 36
    Hinz B, Brune K, Pahl A. Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages. Biochem Biophys Res Commun 2000; 272: 744748.
  • 37
    Ludin A, Itkin T, Gur-Cohen S et al. Monocytes-macrophages that express alpha-smooth muscle actin preserve primitive hematopoietic cells in the bone marrow. Nat Immunol 2012; 13: 10721082.
  • 38
    Shojaei F, Trowbridge J, Gallacher L et al. Hierarchical and ontogenic positions serve to define the molecular basis of human hematopoietic stem cell behavior. Dev Cell 2005; 8: 651663.
  • 39
    Wilson A, Oser GM, Jaworski M et al. Dormant and self-renewing hematopoietic stem cells and their niches. Ann N Y Acad Sci 2007; 1106: 6475.
  • 40
    Simonnet AJ, Nehme J, Vaigot P et al. Phenotypic and functional changes induced in hematopoietic stem/progenitor cells after gamma-ray radiation exposure. Stem Cells 2009; 27: 14001409.
  • 41
    Mohrin M, Bourke E, Alexander D et al. Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell 2010; 7: 174185.
  • 42
    Milyavsky M, Gan OI, Trottier M et al. A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal. Cell Stem Cell 2010; 7: 186197.
  • 43
    Hanson WR. Radiation protection of murine intestine by WR-2721, 16,16-dimethyl prostaglandin E2, and the combination of both agents. Radiat Res 1987; 111: 361373.
  • 44
    Maisin JR, Albert C, Henry A. Reduction of short-term radiation lethality by biological response modifiers given alone or in association with other chemical protectors. Radiat Res 1993; 135: 332337.
  • 45
    Berk LB, Patrene KD, Boggs SS. 16,16-Dimethyl prostaglandin E2 and/or syngeneic bone marrow transplantation increase mouse survival after supra-lethal total body irradiation. Int J Radiat Oncol Biol Phys 1990; 18: 13871392.
  • 46
    Lee SK, Lorenzo JA. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: Correlation with osteoclast-like cell formation. Endocrinology 1999; 140: 35523561.
  • 47
    Winkler IG, Sims NA, Pettit AR et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 2010; 116: 48154828.
  • 48
    Christopher MJ, Rao M, Liu F et al. Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. J Exp Med 2011; 208: 251260.
  • 49
    Chow A, Lucas D, Hidalgo A et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med 2011; 208: 261271.
  • 50
    Stahl CP, Winton EF, Monroe MC et al. Recombinant human granulocyte-macrophage colony-stimulating factor promotes megakaryocyte maturation in nonhuman primates. Exp Hematol 1991; 19: 810816.